Interview with Peter van Tilburg, General Director / President, Cambridge Major…
It has now been 12 years since you co-founded ChemShop. One of the busiest, but probably most exciting moments in that period must have been the merger with CML in…
Address: Cambridge Major Laboratories Europe, B.V., Peelterbaan 2, 6002 NK Weert, Industrial area “De Kempen”, the Netherlands
Tel: ++31 (0)495 549 072
Web: http://www.c-mlabs.com/faceu.html
Cambridge Major Laboratories provides advanced chemistry services to the worlds leading pharmaceutical and biotechnology companies. We boast an impeccable reputation for delivering some of the most challenging projects and meeting the tightest timelines. And Cambridge Major’s reach is truly global in nature, operating four facilities in the US and Europe, serving hundreds of companies across the world.
Our philosophy revolves around strong R&D. With almost 50% of our scientists holding a Ph.D., Cambridge Major is well positioned to deliver on the most challenging and complex chemistry projects. Strong R&D to support early scale up during pre-clinical development will ensure that your molecule will transition into first-in-human studies as smoothly as possible. And we have the resources to provide all of your clinical and commercial API needs.
So when you are looking for a trusted partner to help take your molecule from concept to clinic and beyond, look to Cambridge Major. WE DELIVER.
The Weert facility (formerly ChemShop BV) is a 12,500 square meter site specializing in medicinal chemistry, process development, scale-up, clinical supplies, and low volume commercial supply of API’s. The facility houses fully isolated pilot suites with reactors of up to 1000 liter, and is fully GMP and ISO14001 certified. The facility has a wide range of capabilities including plant scale cryogenics (-100C) and high temperature (300C), high pressure reactions and high vacuum distillations.
It has now been 12 years since you co-founded ChemShop. One of the busiest, but probably most exciting moments in that period must have been the merger with CML in…
After a successful IPO on Nasdaq in May 2015, Galapagos is ready to continue developing its robust portfolio of clinical-stage breakthrough therapies with the potential to revolutionize existing treatment paradigms.…
The future of drug development is about interacting, sharing and collaborating. The President and CEO of Genmab, an international biotechnology company focusing on differentiated antibody therapeutics for the treatment of…
Despite its diminutive size, the Netherlands has historically carried a large weight in the world because of certain cultural endowments: small but united, entrepreneurial, innovative, and externally oriented. During the…
In order to understand the culture behind the business that this association represents, what would you say is the perception of OTC and non-prescriptive drugs in the Netherlands? OTC medicines…
How do you operate in terms of the stakeholder management, with all of your associate members? Do you tend to operate from the committee perspective, or is there an annual…
Having one of the highest penetration rates in Europe, generic medicines play a very important role in the Dutch pharmaceutical market. As this is the principal association for the generics…
While already having worked for Boehringer Ingelheim for quite some time, the end of 2010 marked the completion of your first full year as general manager of this Dutch affiliate.…
Menarini is an extremely proud Italian company in its origins, but also very reliant on international markets. In 2009 approximately 63% of the group’s consolidated revenues came from abroad. What…
When it comes to the pharmaceutical and healthcare industries in the Netherlands, the country has one of the highest generic penetration rates in Europe, it does not have a strong…
WFIA is quite a remarkable organisation that has been, since its inception ten years ago, reporting very good results. The annual results last week showed another strong focus on the…
The Netherlands is famous throughout Europe and the global pharmaceutical community for its research infrastructure – institutes, university hospitals, and public private partnerships. Given this foundation and the size of…
Given the peculiarities of the pharmaceutical industry in the Netherlands, such as the highest generics penetration rate in Europe, a relatively small manufacturing presence and a considerably regulated market, what…
See our Cookie Privacy Policy Here
